| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO And Secretary
1 company
Kellen Scott is a CFO And Secretary at DiaMedica Therapeutics Inc.. Recent SEC Form 4 filings include 6 buys and 0 sells.
Estimated insider holdings value: $189K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2023 | DMAC Diamedica Therapeutics Inc. | CFO And Secretary | Buy | 10,000 | $3.91 | $39,100.00 | +44.9% | -29.4% | -49.2% | |
| Aug 16, 2021 | DMAC Diamedica Therapeutics Inc. | CFO And Secretary | Buy | 10,000 | $3.15 | $31,463.00 | +81.4% | +22.5% | -44.1% | |
| Nov 9, 2020 | DMAC Diamedica Therapeutics Inc. | CFO And Secretary | Buy | 2,000 | $4.19 | $8,386.60 | +19.4% | - | - | |
| Aug 19, 2019 | DMAC Diamedica Therapeutics Inc. | CFO And Secretary | Buy | 3,000 | $2.43 | $7,290.00 | +41.2% | - | - | |
| May 24, 2019 | DMAC Diamedica Therapeutics Inc. | CFO And Secretary | Buy | 4,000 | $2.94 | $11,770.00 | +121.6% | - | - | |
| Dec 11, 2018 | DMAC Diamedica Therapeutics Inc. | CFO And Secretary | Buy | 1,250 | $4.00 | $5,000.00 | +61.3% | - | - |